835619-41-5 Usage
Uses
Used in Pharmaceutical Industry:
Indeglitazar is used as an insulin sensitizer for the treatment of type 2 diabetes, improving insulin sensitivity and glucose metabolism in patients.
Indeglitazar is used as a potential treatment for dyslipidemia and atherosclerosis due to its ability to regulate lipid metabolism and reduce inflammation.
Used in Research and Development:
Indeglitazar is used as a subject of research for further understanding its safety and potential therapeutic uses, particularly in the context of its dual PPARα/γ agonist properties and its implications for metabolic disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 835619-41-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,3,5,6,1 and 9 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 835619-41:
(8*8)+(7*3)+(6*5)+(5*6)+(4*1)+(3*9)+(2*4)+(1*1)=185
185 % 10 = 5
So 835619-41-5 is a valid CAS Registry Number.
835619-41-5Relevant academic research and scientific papers
PPAR ACTIVE COMPOUNDS
-
Page 95-96, (2008/06/13)
Compounds are described that are active on PPARs, including pan-active compounds. Also described are methods for developing or identifying compounds having a desired selectivity profile.
PPAR active compounds
-
, (2008/06/13)
Compounds are described that are active on PPARs, including pan-active compounds. Also described are methods for developing or identifying compounds having a desired selectivity profile.
